HS-20110

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-20110, covering 2025-12-15 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20110 in Participants With Advanced Solid Tumors [Phase 1]